Skip to content
  • About
  • Board
  • News
  • Sign Up
  • Contact

Visit

vjoncology logo
VJHemOnc
Logo
  • Home (current)
  • Diseases
    CLL
    Multiple Myeloma
    Myeloproliferative Neoplasms
    ALL
    AML
    Lymphoma
    View all Diseases
  • Topics
    Transplantation
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    View all Topics
  • Conferences
    ASH
    2019
    MPN Advances Day
    2019
    iwCAR-T
    2019
    COSTEM
    2019
    ESMO
    2019
    iwCLL
    2019
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

flow cytometry

1:44
Is MRD ready for clinical practice?
Lydia Scarfò
3:19
Sample size limitations in MRD
Thomas Kipps
23:38
MRD evaluation: a key component of MM management?
Elena Zamagni et al.
2:43
The value of MRD assessment in CLL
Arnon Kater
1:25
Coupling imaging and molecular techniques to determine MRD in MM
Elena Zamagni
1:47
Depth of MRD assessment in MM
Graham Jackson
3:35
Venetoclax: undetectable peripheral blood MRD status as a therapeutic goal in R/R CLL
Sasanka Handunnetti
3:21
Developments in acute leukemias: biology, therapeutics and monitoring
Richard Stone
1:52
MRD by flow cytometry
Giuseppe Gaipa
4:59
Checkpoint Inhibitors in AML
Naval Daver
5:35
Advanced flow cytometry & CAR-T for the treatment of acute leukemias
Giuseppe Gaipa
2:22
Molecular MRD detection in AML
Peter Valk
1:30
The clinical application of MRD testing in AML
Michael Heuser
19:31
Utilizing MRD for AML in the clinical setting
Jorge Sierra et al.
1:27
CyTOF flow cytometry in determining daratumumab response in myeloma
Francesca Gay
1:57
MRD negativity in ALL
Dieter Hoelzer
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Continue

Please enter your details if you would like to receive the latest hemonc news and updates

Sign up
Disease Channels
  • CLL
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • ALL
  • AML
  • Lymphoma
  • View all
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up
mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJHemOnc logo
The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy